AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19955069 — intervention group
Group type: EXPERIMENTAL
Intervention: Movie
Number of subjects: 38
Study 19955069 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 17418836 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of acarbose
Number of subjects: 0
Study 15119636 — intervention group
Group type: COMPARATOR
Intervention: Dialysate volume of 2.0 L
Number of subjects: 13
Study 15119636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysate volume of 2.5 L
Number of subjects: 13
Study 15119636 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysate volume of 3.0 L
Number of subjects: 13
Study 11515707 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg daily (increased to 10 mg if BP > 140/90 mmHg)
Number of subjects: 64
Study 11515707 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine retard 20 mg twice daily (increased to 40 mg if BP > 140/90 mmHg)
Number of subjects: 64
Study 11515707 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 64
Study 11515707 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine retard
Number of subjects: 64
Study 11515707 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study 11233385 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin GITS
Number of subjects: 54
Study 11233385 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 54
Study 7837756 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum therapy
Number of subjects: 0
Study 7837756 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 2842677 — intervention group
Group type: EXPERIMENTAL
Intervention: Monovalent Japanese encephalitis vaccine (n = 21,628)
Number of subjects: 65224
Study 2842677 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent Japanese encephalitis vaccine (n = 22,080)
Number of subjects: 65224
Study 2842677 — intervention group
Group type: COMPARATOR
Intervention: Tetanus toxoid placebo (n = 21,516)
Number of subjects: 65224
Study 2842677 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccine groups combined
Number of subjects: 65224
Study 31625764 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor nature exposure (room with natural elements)
Number of subjects: 0
Study 31625764 — intervention group
Group type: COMPARATOR
Intervention: Control (room without natural elements)
Number of subjects: 0
Study 29751205 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 0
Study 29751205 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Training (EAET)
Number of subjects: 0
Study 29751205 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 0
Study 28051357 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-assisted case management program
Number of subjects: 61
Study 25360528 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol-preserved graft
Number of subjects: 106
Study 25360528 — intervention group
Group type: COMPARATOR
Intervention: Freeze-dried graft
Number of subjects: 106
Study 23295777 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-alert dispatch workflow with Medical Priority Dispatch System
Number of subjects: 1500
Study 23295777 — intervention group
Group type: COMPARATOR
Intervention: Standard dispatch without pre-alert
Number of subjects: 1500
Study 23295777 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-alert dispatch workflow with Medical Priority Dispatch System in critically ill patients
Number of subjects: 1500
Study 23295777 — intervention group
Group type: COMPARATOR
Intervention: Standard dispatch without pre-alert in critically ill patients
Number of subjects: 1500
Study 21549292 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated pressure change detection (PCD) algorithm using intracardiac pressures measured with an implantable hemodynamic monitor (IHM).
Number of subjects: 274
Study 21549292 — intervention group
Group type: COMPARATOR
Intervention: Intracardiac pressures measured with IHM analyzed using PCD algorithm.
Number of subjects: 274
Study 18817474 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT (655 nm) of 5 J at an energy density of 500 J/cm2 administered at four points along the biceps muscle belly
Number of subjects: 12
Study 18817474 — intervention group
Group type: COMPARATOR
Intervention: Placebo LLLT administered in the same manner
Number of subjects: 12
Study 18817474 — intervention group
Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 12
Study 18817474 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT (655 nm)
Number of subjects: 12
Study 16580286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) followed by oral nifidepine tocolysis (n = 24)
Number of subjects: 54
Study 16580286 — intervention group
Group type: COMPARATOR
Intervention: No tocolysis (n = 30)
Number of subjects: 54
Study 14558283 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 0
Study 14558283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10808210 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD) 2 mg/kg/day intravenously
Number of subjects: 24
Study 10808210 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole 200 mg/day orally
Number of subjects: 24
Study 8827784 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) therapy for 1 week
Number of subjects: 48
Study 8827784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 8827784 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) therapy for 1 week (after discontinuation)
Number of subjects: 48
Study 1306636 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone Dipropionate per nasal spray (400 mcg a day)
Number of subjects: 20
Study 1306636 — intervention group
Group type: COMPARATOR
Intervention: Antihistaminical drugs or ketotifen per os and Disodium chromoglycate per nasal spray
Number of subjects: 20
Study 3910116 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted relaxation (BAR)
Number of subjects: 16
Study 3910116 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 30178599 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled cord traction (n=150)
Number of subjects: 345
Study 30178599 — intervention group
Group type: COMPARATOR
Intervention: Manual removal
Number of subjects: 345
Study 30178599 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled cord traction
Number of subjects: 345
Study 28196498 — intervention group
Group type: EXPERIMENTAL
Intervention: Family and home-related factors including cognitive variables (parental attitude, subjective norm), environmental variables (availability of SSB, parenting practices), and habitual variables (habit strength, taste preference)
Number of subjects: 644
Study 28196498 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethnic background of the child
Number of subjects: 644
Study 24313250 — intervention group
Group type: EXPERIMENTAL
Intervention: T1 (thin, 2 mm or less)
Number of subjects: 97
Study 24313250 — intervention group
Group type: EXPERIMENTAL
Intervention: T2 (thin thickened with allogenic membrane)
Number of subjects: 97
Study 24313250 — intervention group
Group type: COMPARATOR
Intervention: C (thick, more than 2 mm)
Number of subjects: 97
Study 22743670 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) for 2 months
Number of subjects: 81
Study 22743670 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP for 2 months
Number of subjects: 81
Study 22743670 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive Sleep Apnoea (OSA) patients
Number of subjects: 81
Study 21177786 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week hypocaloric diet alone
Number of subjects: 18
Study 21177786 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week hypocaloric diet with aerobic exercise training
Number of subjects: 18
Study 21177786 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight maintenance after active weight loss
Number of subjects: 18
Study 19520016 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention for GPs addressing knowledge, skills, and attitudes about first-episode psychosis
Number of subjects: 179
Study 19520016 — intervention group
Group type: COMPARATOR
Intervention: Control practices (no educational intervention)
Number of subjects: 179
Study 17712157 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation program
Number of subjects: 32
Study 17712157 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational program
Number of subjects: 32
Study 15358868 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual search tasks in adults with autism
Number of subjects: 0
Study 12351279 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desipramine
Number of subjects: 0
Study 12351279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9893687 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnification
Number of subjects: 52
Study 9893687 — intervention group
Group type: COMPARATOR
Intervention: No magnification (Control)
Number of subjects: 52
Study 8042723 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil on induction of anaesthesia (40 micrograms.kg‐1)
Number of subjects: 40
Study 8042723 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil after the skin incision (40 micrograms.kg‐1)
Number of subjects: 40
Study 3409432 — intervention group
Group type: EXPERIMENTAL
Intervention: Control blood glucose plus acupuncture
Number of subjects: 27
Study 3409432 — intervention group
Group type: COMPARATOR
Intervention: Simple control blood glucose
Number of subjects: 27
Study 30485612 — intervention group
Group type: EXPERIMENTAL
Intervention: heartfailurematters.org website
Number of subjects: 450
Study 30485612 — intervention group
Group type: EXPERIMENTAL
Intervention: e-health adjusted care pathway
Number of subjects: 450
Study 30485612 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 450
Study 28341415 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic strategy based on CA125: high dose if CA125 > 35 U/mL, low doses otherwise
Number of subjects: 0
Study 28341415 — intervention group
Group type: COMPARATOR
Intervention: Standard diuretic strategy: titration based on conventional clinical and biochemical evaluation
Number of subjects: 0
Study 28341415 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic strategy based on CA125
Number of subjects: 0
Study 28341415 — intervention group
Group type: COMPARATOR
Intervention: Standard diuretic strategy
Number of subjects: 0
Study 25981372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion at 4 kcal/min (ID4)
Number of subjects: 19
Study 25981372 — intervention group
Group type: COMPARATOR
Intervention: Intraduodenal glucose infusion at 2 kcal/min (ID2)
Number of subjects: 19
Study 23063790 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonophoresis of piroxicam (PhP) with 4 grams of 0.5% piroxicam gel, 20mg of piroxicam drug, ultrasound program, continuous mode, 1.0W/cm(2), 10 minutes per session, 5 times per week for 2 weeks.
Number of subjects: 46
Study 23063790 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound therapy (UT) using nondrug coupling gel, ultrasound program, continuous mode, 1.0W/cm(2), 10 minutes per session, 5 times per week for 2 weeks.
Number of subjects: 46
Study 21750201 — intervention group
Group type: EXPERIMENTAL
Intervention: Cixutumumab (6 mg/kg IV) and Temsirolimus (25 mg IV)
Number of subjects: 42
Study 21750201 — intervention group
Group type: EXPERIMENTAL
Intervention: Cixutumumab alone or combined with Temsirolimus
Number of subjects: 42
Study 21750201 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET/CT
Number of subjects: 42
Study 18843280 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 0
Study 18843280 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study 18843280 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study 16449096 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 27
Study 16449096 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital
Number of subjects: 27
Study 14708410 — intervention group
Group type: EXPERIMENTAL
Intervention: H2RA-based triple regimen (20 mg famotidine, 1.0 g amoxicillin, 0.4 g metronidazole) for 1 week
Number of subjects: 0
Study 14708410 — intervention group
Group type: EXPERIMENTAL
Intervention: H2RA-based triple regimen (20 mg famotidine, 1.0 g amoxicillin, 0.4 g metronidazole) for 2 weeks
Number of subjects: 0
Study 14708410 — intervention group
Group type: COMPARATOR
Intervention: PPI-based triple regimen (20 mg omeprazole, 1.0 g amoxicillin, 0.4 g metronidazole) for 1 week
Number of subjects: 0
Study 14708410 — intervention group
Group type: COMPARATOR
Intervention: PPI-based triple regimen (20 mg omeprazole, 1.0 g amoxicillin, 0.4 g metronidazole) for 2 weeks
Number of subjects: 0
Study 10829335 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-Step, Minnesota Model treatment (completed treatment)
Number of subjects: 245
Study 10829335 — intervention group
Group type: COMPARATOR
Intervention: 12-Step, Minnesota Model treatment (incomplete treatment)
Number of subjects: 245
Study 10829335 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group
Number of subjects: 245
Study 9305460 — intervention group
Group type: EXPERIMENTAL
Intervention: lorazepam 2 mg
Number of subjects: 27
Study 8321672 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of essential oils of lavender species 1
Number of subjects: 28
Study 8321672 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of essential oils of lavender species 2
Number of subjects: 28
Study 2425156 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.15 mg/kg i.v.)
Number of subjects: 6
Study 2425156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (0.02 mg/kg i.v.)
Number of subjects: 6
Study 2425156 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Pindolol (both drugs during exercise)
Number of subjects: 6
Study 2425156 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and Pindolol (at equipotent dosages)
Number of subjects: 6
Study 29996883 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 72
Study 29996883 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated non-surgical periodontal therapy
Number of subjects: 72
Study 29996883 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-of-care and Repeated non-surgical periodontal therapy
Number of subjects: 72
Study 27821313 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic early palliative care (EPC)
Number of subjects: 207
Study 27821313 — intervention group
Group type: COMPARATOR
Intervention: On-demand early palliative care (EPC)
Number of subjects: 207
Study 24345398 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (100 mg)
Number of subjects: 19
Study 24345398 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ascorbic acid)
Number of subjects: 19
Study 22745239 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic human acyl ghrelin (0.2 or 0.6 nmol/kg · h)
Number of subjects: 14
Study 22745239 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 14
Study 20149756 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 125
Study 20149756 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 125
Study 20149756 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 125
Study 18307127 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical vestibular stimulation
Number of subjects: 2
Study 18307127 — intervention group
Group type: EXPERIMENTAL
Intervention: Head rotation
Number of subjects: 2
Study 16083703 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 458
Study 16083703 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-I
Number of subjects: 458
Study 16083703 — intervention group
Group type: EXPERIMENTAL
Intervention: IGF-I/IGFBP-3 ratio
Number of subjects: 458
Study 16083703 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral adipose tissue (VAT)
Number of subjects: 458
Study 12746252 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmozyme
Number of subjects: 25
Study 12746252 — intervention group
Group type: COMPARATOR
Intervention: Normal saline aerosol
Number of subjects: 25
Study 10485385 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets)
Number of subjects: 126
Study 10485385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 8523302 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-intermittent dilatation (SID) group
Number of subjects: 51
Study 8523302 — intervention group
Group type: COMPARATOR
Intervention: No dilatation (non-SID) group
Number of subjects: 51
Study 2201256 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour infusion of amphotericin B (group A)
Number of subjects: 12
Study 2201256 — intervention group
Group type: COMPARATOR
Intervention: 4-hour infusion of amphotericin B (group B)
Number of subjects: 12
Study 6109538 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol 10 mg daily for 7 days
Number of subjects: 2
Study 6109538 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol 20 mg daily for 7 days
Number of subjects: 2
Study 6109538 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol increasing doses up to 60 mg/day for 15 days
Number of subjects: 2
Study 31734213 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD-RADS
Number of subjects: 3840
Study 31734213 — intervention group
Group type: COMPARATOR
Intervention: Traditional stenosis-based assessments
Number of subjects: 3840
Study 31574792 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (GCBT) for 8 consecutive weeks, 2.5-hour sessions each week
Number of subjects: 28
Study 31574792 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 28
Study 27518489 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 168
Study 27518489 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 168
Study 27518489 — intervention group
Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 168
Study 26032174 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent simulator (Group 1)
Number of subjects: 36
Study 26032174 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-transparent simulator (Group 2)
Number of subjects: 36
Study 26032174 — intervention group
Group type: COMPARATOR
Intervention: Verbal instruction only (Group 3)
Number of subjects: 36
Study 23403768 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial pacing (Group I)
Number of subjects: 240
Study 23403768 — intervention group
Group type: COMPARATOR
Intervention: Single atrial pacing (Group II)
Number of subjects: 240
Study 23403768 — intervention group
Group type: COMPARATOR
Intervention: No pacing (Group III)
Number of subjects: 240
Study 21489609 — intervention group
Group type: EXPERIMENTAL
Intervention: Ze 339
Number of subjects: 18
Study 21489609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 21489609 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine
Number of subjects: 18
Study 19181592 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.06 mg/kg as a priming dose
Number of subjects: 60
Study 19181592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.01 mg/kg as a priming dose
Number of subjects: 60
Study 19181592 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 60
Study 17971314 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium carbonate
Number of subjects: 30
Study 17971314 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 30
Study 14747211 — intervention group
Group type: COMPARATOR
Intervention: Established plus DASH (Group C)
Number of subjects: 0
Study 14747211 — intervention group
Group type: COMPARATOR
Intervention: Established (Group B)
Number of subjects: 0
Study 14747211 — intervention group
Group type: COMPARATOR
Intervention: Advice only (Group A)
Number of subjects: 0
Study 14725687 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg/orally, twice daily)
Number of subjects: 40
Study 14725687 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/orally, twice daily)
Number of subjects: 40
Study 14725687 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined metformin (850 mg/orally, twice daily) + flutamide (250 mg/orally, twice daily)
Number of subjects: 40
Study 14725687 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric diet alone
Number of subjects: 40
Study 10506726 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 150 U/kg, 3 times per week; increased to 300 U/kg and 450 U/kg if nonresponsive
Number of subjects: 30
Study 10506726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EPO)
Number of subjects: 30
Study 10506726 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment group
Number of subjects: 30
Study 7863986 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (n = 9)
Number of subjects: 19
Study 7863986 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (n = 10)
Number of subjects: 19
Study 7863986 — intervention group
Group type: COMPARATOR
Intervention: Control (Resting conditions)
Number of subjects: 19
Study 7863986 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing
Number of subjects: 19
Study 2382455 — intervention group
Group type: EXPERIMENTAL
Intervention: Savary-Gilliard dilators
Number of subjects: 60
Study 2382455 — intervention group
Group type: COMPARATOR
Intervention: Balloon dilatation
Number of subjects: 60
Study 6794938 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG)
Number of subjects: 27
Study 6794938 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 27